• About Us
    • Contact Us
    • Login
    • ObGFirst
  • COVID-19
  • Alerts
  • OB
  • 2T US Atlas
  • The Genome
  • GYN
    • GYN
    • Sexual Health
  • Primary Care
  • Your Practice
  • GrandRounds
  • My Bookshelf
  • Now@ObG
  • Media
About Us Contact Us Login ObGFirst
  • COVID-19
  • Alerts
  • OB
  • 2T US Atlas
  • The Genome
  • GYN
    • GYN
    • Sexual Health
  • Primary Care
  • Your Practice
  • GrandRounds
  • My Bookshelf
  • Now@ObG
  • Media
Grand Rounds

Homicide as a Leading Cause of Maternal Mortality in the US

image_pdfFavoriteLoadingFavorite

BACKGROUND AND PURPOSE:

  • Wallace et al. (Obstetrics & Gynecology, 2021) sought to determine the national pregnancy-associated homicide prevalence

METHODS:

  • Population
    • Female decedents aged 10 to 44 in the US
    • Data derived from the National Center for health Statistics 2018 and 2019
  • Study design
    • Pregnancy-associated homicide mortality was compared to homicide mortality among non-pregnant, non-postpartum women and direct maternal causes of death
    • Stratification performed by race/ethnicity and age         
  • Outcomes
    • 2-year pregnancy-associated homicide mortality ratio (deaths/100,000 live births)
    • Comparative risk of homicide in the perinatal period (pregnancy and up to 1 year postpartum) vs nonpregnant, nonpostpartum females

RESULTS:

  • 4705 homicide victims of reproductive age
  • Homicide rate among women in the perinatal period was 16% higher than in non-pregnant, non-postpartum women (P<0.05)
    • Perinatal: 3.62 deaths per 100,000 live births
    • Non-pregnant, non-postpartum: 3.12 deaths per 100,000 population
  • Homicide mortality ratios during pregnancy or within 42 days of the end of pregnancy exceeded hypertensive disorders, hemorrhage, and infection, by more than twofold
  • Pregnancy was associated with a significantly elevated homicide risk among
    • Black women
    • Girls and younger women (age 10 to 24 years), across racial and ethnic subgroups
  • Two thirds of the fatal injuries occurred in the home (64.8%), and most involved firearms (69.2%)

CONCLUSION:

  • In the US, homicide is the leading cause of death for women in the perinatal period
  • The authors state

Although this is important information for monitoring progress towards the elimination of pregnancy-associated homicide, information alone will do nothing to save lives

Already, increasing efforts within individual states have been devoted to identifying and reviewing maternal deaths due to violence to make recommendations at individual, community, system, and policy levels for the prevention of future cases

Although encouraging, a commitment to the actual implementation of policies and investments known to be effective at protecting and the promoting the health and safety of girls and women must follow

Learn More – Primary Sources:

Homicide During Pregnancy and the Postpartum Period in the United States, 2018–2019

Want to stay on top of key guidelines and research papers?

ObGFirst® – Try It Free! »

image_pdfFavoriteLoadingFavorite
< Previous
All Grand Rounds Posts
Next >

Related ObG Topics:

Maternal Near-Misses: An Investigation of Incidence and Causes
Sepsis and Sepsis-Related Maternal Mortality in the U.S. – Does it Happen More Than We Think?
How Do Health Outcomes in the Richest Counties in the US Compare to Those of Average Citizens in Other Developed Nations?

Sections

  • COVID-19
  • Alerts
  • OB
  • GYN
    • GYN
    • Sexual Health
  • 2T US Atlas
  • The Genome
  • Primary Care
  • Your Practice
  • Grand Rounds
  • My Bookshelf
  • Now@ObG
  • Media

Are you an
ObG Insider?

Get specially curated clinical summaries delivered to your inbox every week for free

  • Site Map/
  • © ObG Project/
  • Terms and Conditions/
  • Privacy/
  • Contact Us/
© ObG Project
SSL Certificate


  • Already an ObGFirst Member?
    Welcome back

    Log In

    Want to sign up?
    Get guideline notifications
    CME Included

    Sign Up

Get Guideline Alerts Direct to Your Phone
Try ObGFirst Free!

Sign In

Lost your password?

Sign Up for ObGFirst and Stay Ahead

  • - Professional guideline notifications
  • - Daily summary of a clinically relevant
    research paper
  • - Includes 1 hour of CME every month

ObGFirst Free Trial

Already a Member of ObGFirst®?

Please log in to ObGFirst to access the 2T US Atlas

Password Trouble?

Not an ObGFirst® Member Yet?

  • - Access 2T US Atlas
  • - Guideline notifications
  • - Daily research paper summaries
  • - And lots more!
ObGFirst Free Trial

Media - Internet

Computer System Requirements

OBG Project CME requires a modern web browser (Internet Explorer 10+, Mozilla Firefox, Apple Safari, Google Chrome, Microsoft Edge). Certain educational activities may require additional software to view multimedia, presentation, or printable versions of their content. These activities will be marked as such and will provide links to the required software. That software may be: Adobe Flash, Apple QuickTime, Adobe Acrobat, Microsoft PowerPoint, Windows Media Player, or Real Networks Real One Player.

Disclosure of Unlabeled Use

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications.

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Disclaimer

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information
presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.

Jointly provided by

NOT ENOUGH CME HOURS

It appears you don't have enough CME Hours to take this Post-Test. Feel free to buy additional CME hours or upgrade your current CME subscription plan

Subscribe

JOIN OBGFIRST AND GET CME/CE CREDITS

One of the benefits of an ObGFirst subscription is the ability to earn CME/CE credits from the ObG entries you read. Tap the button to learn more about ObGFirst

Learn More
Leaving ObG Website

You are now leaving the ObG website and on your way to PRIORITY at UCSF, an independent website. Therefore, we are not responsible for the content or availability of this site